General Info

Neurocrine Biosciences, headquartered in San Diego, is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Incorporated in 1992, its products address some of the largest pharmaceutical markets in the world, including insomnia, female and male disorders, anxiety, depression, diabetes, irritable bowel syndrome, eating disorders, pain, and autoimmunity. The company s research group focuses on developing small molecule compounds against G-protein coupled receptors and clinical development. One of its business strategies is to utilize strategic alliances to enhance its development and commercialization capabilities. Neurocrine Biosciences has alliances with various pharmaceutical companies, including Pfizer, GlaxoSmithKline, Wyeth, and Eli Lilly and Company.